Product Program year 2024 Source: CMS Open Payments

Ganirelix Acetate

Biological Ganirelix

NDC 0548-5001-00

Open in the dashboard

General payments

$2,493

21 payments

Research payments

$0

0 payments

Through program year 2024, $2,493 in general payments and $0 in research payments were reported against Ganirelix Acetate (Ganirelix).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2024 General $2,493 21

Breakdown

Who paid General payments · program year 2024
  1. Granata Bio Corporation $2,493 21 payments
Top recipients General payments · program year 2024
  1. Karina Stroker Nurse Practitioner, Family · Warrington, PA $1,112 45% · 2 payments
  2. Ariel Dunn Reproductive Endocrinology · Fort Sam Houston, TX $154 6% · 2 payments
  3. Peter Lindner Reproductive Endocrinology · Bethesda, MD $154 6% · 2 payments
  4. Micah Hill Reproductive Endocrinology · Rockville, MD $103 4% · 1 payment
  5. Shelley Dolitsky Obstetrics & Gynecology · Columbia, MD $103 4% · 1 payment

The top 5 of 18 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Nurse Practitioner, Family Nurse Practitioner $1,112 46% · 1 practitioner
  2. Reproductive Endocrinology Obstetrics & Gynecology $870 36% · 10 practitioners
  3. Obstetrics & Gynecology $461 19% · 6 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Pennsylvania $1,112 45% · 1 recipient
  2. Maryland $920 37% · 11 recipients
  3. Georgia $103 4% · 1 recipient
  4. New Jersey $103 4% · 1 recipient
  5. District of Columbia $103 4% · 1 recipient

The top 5 of 8 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

21 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record